Anticipated Resection Ratio (ARR) Based Flap Selection for Volume‐Replacement Oncoplastic Breast‐Conserving Surgery: 130 Breast Cancer Patients Cohort From a South Asian Tertiary Cancer Center
World Journal of Surgery · 2026
DOI: 10.1002/wjs.70569 ↗At a glance
Journal article in World Journal of Surgery, 2026. Written by Ashutosh Mishra and 12 co-authors. Institution: Department of Surgical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital (IRCH), All India Institute of Medical Sciences, New Delhi, Indi…. Major MEDLINE topics: Breast Neoplasms, Mastectomy, Segmental, Mammaplasty, Perforator Flap. 31 references.
Topics: Onkologische Pflege
Abstract (original language)
Background
Volume‐replacement oncoplastic breast‐conserving surgery (VR‐OBCS) reconstructs the lumpectomy cavity with autologous tissue and spares the contralateral breast. Chest‐wall perforator flaps (CWPFs)—lateral, anterior, and medial intercostal artery perforator (LICAP, AICAP, MICAP) flaps—together with a pedicled latissimus dorsi (LD) flap form the usual toolkit, but most programs depend on hand‐held color Doppler for perforator mapping and indocyanine‐green (ICG) angiography for perfusion assessment, neither of which is widely available in resource‐limited oncology units. We evaluated whether a structured radiological assessment using ARR, BEV, and aORV could facilitate preoperative planning for volume replacement oncoplastic breast‐conserving surgery (VR‐OBCS).
Methods
Consecutive women undergoing VR‐OBCS at an Indian tertiary cancer center (January 2023–March 2025) were reviewed retrospectively. Eligibility required an anticipated resection ratio (ARR) ≥ 0.15 or expected poor cosmesis after standard BCS; an ARR of 0.20–0.40 was the usual planning range for perforator‐based volume replacement. Flap choice followed a quadrant‐based map; the pedicled LD flap was reserved for defined indications. Perforator zones were identified by intercostal‐space counting; color Doppler and ICG were never used. The primary endpoint was primary R0 resection (SSO–ASTRO 2014 “no ink on tumor”); secondary endpoints included flap loss, Clavien–Dindo morbidity, oncological events, and 12‐month BREAST‐Q satisfaction.
Results
One hundred thirty women (mean age 47.7 ± 5.5 years) were treated: LICAP in 68 (52.3%), MICAP in 29 (22.3%), AICAP in 21 (16.2%), and pedicled LD in 12 (9.2%); 42.3% received neoadjuvant chemotherapy. Primary R0 was 95.4%, with all six margin‐positive women achieving R0 at re‐excision (final R0 100%). No total or partial flap loss occurred. Thirty‐day morbidity was 25.4% (maximum Clavien–Dindo IIIa) and late morbidity 16.9%. At a median follow‐up of 15.9 months (IQR 12.3–22.6), no locoregional or distant recurrence and no disease‐related death were recorded. The median BREAST‐Q Satisfaction‐with‐Breasts score was 86 (IQR 78–92); none preferred mastectomy.
Conclusions
Simple preoperative calculation of BEV, aORV, and ARR can guide selection between standard or type I oncoplastic BCS, perforator‐flap volume replacement, and muscle‐based reconstruction. This approach achieved reliable margin clearance, preserved flap viability, and high patient satisfaction without Doppler or ICG, making it a practical planning tool for resource‐limited centers.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Surgical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital (IRCH), All India Institute of Medical Sciences, New Delhi, India.
- Department of Radio Diagnosis, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital (IRCH), All India Institute of Medical Sciences, New Delhi, India.
- Department of Medical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital (IRCH), All India Institute of Medical Sciences, New Delhi, India.
- Department of Surgical Oncology, National Cancer Institute, All India Institute of Medical Sciences, Jhajjar, Haryana, India.
- Department of Oncoanaesthesia & Palliative Medicine, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital (IRCH), All India Institute of Medical Sciences, New Delhi, India.
- Department of Radiation Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital (IRCH), All India Institute of Medical Sciences, New Delhi, India.
ORCID profiles: Ashutosh Mishra, Gajendra Pandit, Anik Rathee, Ekta Dhamija, Ajay Gogia, Amit Kumar, Atul Batra, Jyoutishman Saikia, Sachidanand J Bharati, Babul Bansal, Surendra Saini, Sandeep Mathur, Sunil Kumar
Cite
APA
Mishra, A., Pandit, G., Rathee, A., Dhamija, E., Gogia, A., Kumar, A., Batra, A., Saikia, J., Bharati, S. J., Bansal, B., Saini, S., Mathur, S., & Kumar, S. (2026). Anticipated Resection Ratio (ARR) Based Flap Selection for Volume‐Replacement Oncoplastic Breast‐Conserving Surgery: 130 Breast Cancer Patients Cohort From a South Asian Tertiary Cancer Center. World Journal of Surgery. https://doi.org/10.1002/wjs.70569
Vancouver
Mishra A, Pandit G, Rathee A, Dhamija E, Gogia A, Kumar A, et al. Anticipated Resection Ratio (ARR) Based Flap Selection for Volume‐Replacement Oncoplastic Breast‐Conserving Surgery: 130 Breast Cancer Patients Cohort From a South Asian Tertiary Cancer Center. World Journal of Surgery. 2026. doi:10.1002/wjs.70569
BibTeX
@article{Mishra2026,
author = {Mishra, Ashutosh and Pandit, Gajendra and Rathee, Anik and Dhamija, Ekta and Gogia, Ajay and Kumar, Amit and Batra, Atul and Saikia, Jyoutishman and Bharati, Sachidanand J and Bansal, Babul and Saini, Surendra and Mathur, Sandeep and Kumar, Sunil},
title = {Anticipated Resection Ratio (ARR) Based Flap Selection for Volume‐Replacement Oncoplastic Breast‐Conserving Surgery: 130 Breast Cancer Patients Cohort From a South Asian Tertiary Cancer Center},
journal = {World Journal of Surgery},
year = {2026},
doi = {10.1002/wjs.70569}
}
EUVIMED